Itron, Inc. $ITRI Shares Sold by Aristotle Capital Boston LLC

Aristotle Capital Boston LLC lowered its position in Itron, Inc. (NASDAQ:ITRI) by 2.6% in the fourth quarter, Holdings Channel.com reports. The firm owned 295,550 shares of the scientific and technical instruments company’s stock after selling 8,010 shares during the quarter. Itron makes up about 1.5% of Aristotle Capital Boston LLC’s holdings, making the stock its 12th largest position. Aristotle Capital Boston LLC’s holdings in Itron were worth $27,445,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Employees Retirement System of Texas acquired a new stake in Itron in the third quarter valued at about $32,000. Private Trust Co. NA lifted its position in Itron by 112.4% in the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after purchasing an additional 145 shares during the period. Optiver Holding B.V. acquired a new stake in Itron in the third quarter valued at about $36,000. Northwestern Mutual Wealth Management Co. lifted its position in Itron by 343.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock valued at $46,000 after purchasing an additional 268 shares during the period. Finally, Aster Capital Management DIFC Ltd acquired a new stake in Itron in the third quarter valued at about $44,000. Institutional investors and hedge funds own 96.19% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ITRI shares. Raymond James Financial started coverage on shares of Itron in a research report on Tuesday, April 21st. They set an “underperform” rating for the company. Stephens reiterated an “overweight” rating and set a $130.00 price target on shares of Itron in a research report on Wednesday, May 20th. Zacks Research upgraded shares of Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Roth Mkm reiterated a “buy” rating and set a $136.00 price target on shares of Itron in a research report on Wednesday, April 29th. Finally, TD Cowen reduced their price target on shares of Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Eight investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Itron presently has an average rating of “Moderate Buy” and a consensus price target of $131.22.

Itron Trading Down 2.3%

Shares of ITRI opened at $79.26 on Thursday. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.66 and a quick ratio of 2.24. The firm has a 50 day simple moving average of $85.47 and a 200-day simple moving average of $92.15. Itron, Inc. has a 1-year low of $77.77 and a 1-year high of $142.00. The stock has a market cap of $3.51 billion, a price-to-earnings ratio of 12.64, a price-to-earnings-growth ratio of 0.71 and a beta of 1.33.

Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.23. Itron had a net margin of 12.31% and a return on equity of 19.54%. The business had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. During the same period last year, the company posted $1.52 EPS. The company’s revenue was down 3.3% on a year-over-year basis. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Equities analysts forecast that Itron, Inc. will post 6.01 EPS for the current fiscal year.

Insider Transactions at Itron

In other news, SVP John F. Marcolini sold 322 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total transaction of $27,167.14. Following the completion of the transaction, the senior vice president directly owned 24,689 shares of the company’s stock, valued at $2,083,010.93. This trade represents a 1.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 319 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $26,914.03. Following the transaction, the senior vice president directly owned 29,100 shares of the company’s stock, valued at approximately $2,455,167. This trade represents a 1.08% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 3,946 shares of company stock valued at $324,420 in the last ninety days. Corporate insiders own 1.77% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.